BrainsWay BRSYF Stock
BrainsWay Price Chart
BrainsWay BRSYF Financial and Trading Overview
| BrainsWay stock price | 15.13 USD |
| Previous Close | 15.13 USD |
| Open | 13.54 USD |
| Bid | 12.85 USD x 10000 |
| Ask | 16.63 USD x 10000 |
| Day's Range | 13.54 - 13.55 USD |
| 52 Week Range | 5.49 - 16.84 USD |
| Volume | 300 USD |
| Avg. Volume | 13 USD |
| Market Cap | 543.75M USD |
| Beta (5Y Monthly) | 0.153 |
| PE Ratio (TTM) | 61.59091 |
| EPS (TTM) | 0.22 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BRSYF Valuation Measures
| Enterprise Value | 525.53M USD |
| Trailing P/E | 61.59091 |
| Forward P/E | 104.230774 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.671886 |
| Price/Book (mrq) | 6.8227596 |
| Enterprise Value/Revenue | 9.348 |
| Enterprise Value/EBITDA | 79.433 |
Trading Information
BrainsWay Stock Price History
| Beta (5Y Monthly) | 0.153 |
| 52-Week Change | 123.15% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 16.84 USD |
| 52 Week Low | 5.49 USD |
| 50-Day Moving Average | 16.47 USD |
| 200-Day Moving Average | 11.39 USD |
BRSYF Share Statistics
| Avg. Volume (3 month) | 13 USD |
| Avg. Daily Volume (10-Days) | 30 USD |
| Shares Outstanding | 40.13M |
| Float | 28.44M |
| Short Ratio | N/A |
| % Held by Insiders | 9.51% |
| % Held by Institutions | 10.69% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 15.57% |
| Operating Margin (ttm) | 12.91% |
| Gross Margin | 75.50% |
| EBITDA Margin | 11.76% |
Management Effectiveness
| Return on Assets (ttm) | 3.30% |
| Return on Equity (ttm) | 12.55% |
Income Statement
| Revenue (ttm) | 56.22M USD |
| Revenue Per Share (ttm) | 1.47 USD |
| Quarterly Revenue Growth (yoy) | 34.59% |
| Gross Profit (ttm) | 42.45M USD |
| EBITDA | 6.62M USD |
| Net Income Avi to Common (ttm) | 8.76M USD |
| Diluted EPS (ttm) | 0.22 |
| Quarterly Earnings Growth (yoy) | 106.89% |
Balance Sheet
| Total Cash (mrq) | 58.64M USD |
| Total Cash Per Share (mrq) | 1.54 USD |
| Total Debt (mrq) | 6.71M USD |
| Total Debt/Equity (mrq) | 8.85 USD |
| Current Ratio (mrq) | 3.338 |
| Book Value Per Share (mrq) | 1.986 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 13.65M USD |
| Levered Free Cash Flow (ttm) | 3.03M USD |
Profile of BrainsWay
| Country | United States |
| State | N/A |
| City | Jerusalem |
| Address | 16 Hartum St |
| ZIP | 9777516 |
| Phone | 972 2 582 4030 |
| Website | https://www.brainsway.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 129 |
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Q&A For BrainsWay Stock
What is a current BRSYF stock price?
BrainsWay BRSYF stock price today per share is 15.13 USD.
How to purchase BrainsWay stock?
You can buy BRSYF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BrainsWay?
The stock symbol or ticker of BrainsWay is BRSYF.
Which industry does the BrainsWay company belong to?
The BrainsWay industry is Medical Devices.
How many shares does BrainsWay have in circulation?
The max supply of BrainsWay shares is 40.13M.
What is BrainsWay Price to Earnings Ratio (PE Ratio)?
BrainsWay PE Ratio is 68.77273000 now.
What was BrainsWay earnings per share over the trailing 12 months (TTM)?
BrainsWay EPS is 0.22 USD over the trailing 12 months.
Which sector does the BrainsWay company belong to?
The BrainsWay sector is Healthcare.